Skip to content

256840.KQ

BNC Korea Co., Ltd.

KOE · Healthcare · Drug Manufacturers - Specialty & Generic · KR

KRW 2,620.00
−1.50%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue91.2B95.9B89.2B81.0B42.3B
Cost of Revenue59.1B56.5B47.5B45.0B27.0B
Gross Profit32.0B39.4B41.7B36.0B15.3B
Operating Expenses
R&D Expense5.7B5.1B2.7B5.0B5.4B
SG&A Expense29.8B12.2B8.9B7.6B19.5B
General & Admin Expense20.1B2.7B2.8B3.1B3.2B
Selling & Marketing Expense2.3B9.5B6.0B4.6B7.8B
Other Expenses4.3B20.3B19.5B12.6B12.3B
Total Operating Expenses37.9B37.6B31.0B25.2B24.9B
Cost and Expenses97.1B94.2B78.5B70.2B52.4B
Operating Income (EBIT)(5.9B)1.7B10.7B10.8B(10.1B)
Non-Operating
Interest Income2.5B2.7B2.8B3.5B2.2B
Interest Expense783.1M629.9M334.4M679.7M1.9B
Net Interest Income1.7B2.1B2.5B2.8B313.8M
Other Non-Op Income/Expense2.4B2.6B4.9B11.7B(35.8B)
Non-Operating Income (excl Interest)(786.0M)(3.2B)(5.3B)(7.6B)33.9B
EBT (Pre-Tax Income)(3.5B)4.3B15.7B17.7B(45.9B)
Income Tax Expense2.8B2.3B2.4B(8.4B)(1.3B)
Bottom Line
Net Income(4.7B)2.8B13.3B25.7B(44.7B)
Earnings from Cont. Ops(6.4B)2.0B13.3B26.1B(44.5B)
Earnings from Discont. Ops(220.0K)
Bottom Line Net Income(4.7B)2.8B13.3B25.7B(44.7B)
Per Share
Basic EPS(₩74)₩45₩199₩388(₩716)
Diluted EPS(₩74)₩45₩198₩334(₩711)
Revenue Per Share₩1,333₩1,535₩1,338₩1,224₩678
Shares
Basic Shares Outstanding68.4M62.5M66.7M66.2M62.4M
Diluted Shares Outstanding68.4M62.5M66.8M67.5M62.9M
Profitability Metrics
EBITDA7.4B16.3B25.3B26.5B(38.8B)
D&A12.1B11.4B9.3B8.1B5.1B
EBIT(4.7B)5.0B16.0B18.4B(43.9B)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026